These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 34200386)

  • 1. Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene.
    Pyke AT; Nair N; van den Hurk AF; Burtonclay P; Nguyen S; Barcelon J; Kistler C; Schlebusch S; McMahon J; Moore F
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34200386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference.
    Taylor JK; Coleman CM; Postel S; Sisk JM; Bernbaum JG; Venkataraman T; Sundberg EJ; Frieman MB
    J Virol; 2015 Dec; 89(23):11820-33. PubMed ID: 26378163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consecutive deletions in a unique Uruguayan SARS-CoV-2 lineage evidence the genetic variability potential of accessory genes.
    Panzera Y; Calleros L; Goñi N; Marandino A; Techera C; Grecco S; Ramos N; Frabasile S; Tomás G; Condon E; Cortinas MN; Ramas V; Coppola L; Sorhouet C; Mogdasy C; Chiparelli H; Arbiza J; Delfraro A; Pérez R
    PLoS One; 2022; 17(2):e0263563. PubMed ID: 35176063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
    Silvas JA; Vasquez DM; Park JG; Chiem K; Allué-Guardia A; Garcia-Vilanova A; Platt RN; Miorin L; Kehrer T; Cupic A; Gonzalez-Reiche AS; Bakel HV; García-Sastre A; Anderson T; Torrelles JB; Ye C; Martinez-Sobrido L
    J Virol; 2021 Aug; 95(17):e0040221. PubMed ID: 34133899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication kinetics and infectivity of SARS-CoV-2 variants of concern in common cell culture models.
    Mautner L; Hoyos M; Dangel A; Berger C; Ehrhardt A; Baiker A
    Virol J; 2022 Apr; 19(1):76. PubMed ID: 35473640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging SARS-CoV-2 Genotypes Show Different Replication Patterns in Human Pulmonary and Intestinal Epithelial Cells.
    de Souza GAP; Le Bideau M; Boschi C; Ferreira L; Wurtz N; Devaux C; Colson P; La Scola B
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression.
    Nemudryi A; Nemudraia A; Wiegand T; Nichols J; Snyder DT; Hedges JF; Cicha C; Lee H; Vanderwood KK; Bimczok D; Jutila MA; Wiedenheft B
    Cell Rep; 2021 Jun; 35(9):109197. PubMed ID: 34043946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variant.
    Yinda CK; Port JR; Bushmaker T; Fischer RJ; Schulz JE; Holbrook MG; Shaia C; de Wit E; van Doremalen N; Munster VJ
    Emerg Microbes Infect; 2021 Dec; 10(1):1284-1292. PubMed ID: 34120579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement of the N-terminal region of nonstructural protein 1 in cis for SARS-CoV-2 defective RNA replication.
    Terasaki K; Makino S
    J Virol; 2024 Sep; 98(9):e0090024. PubMed ID: 39194239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of SARS-CoV-2 accessory proteins in immunopathogenesis.
    Ito H; Tamura T; Wang L; Mori K; Tsuda M; Suzuki R; Suzuki S; Yoshimatsu K; Tanaka S; Fukuhara T
    Microbiol Immunol; 2024 Jul; 68(7):237-247. PubMed ID: 38837257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).
    Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S
    Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.
    Chaudhry MZ; Eschke K; Hoffmann M; Grashoff M; Abassi L; Kim Y; Brunotte L; Ludwig S; Kröger A; Klawonn F; Pöhlmann SH; Cicin-Sain L
    J Virol; 2022 Mar; 96(5):e0218621. PubMed ID: 35019723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Plaque Size, Thermal Stability, and Replication Rate among SARS-CoV-2 Variants of Concern.
    Jeong GU; Yoon GY; Moon HW; Lee W; Hwang I; Kim H; Kim KD; Kim C; Ahn DG; Kim BT; Kim SJ; Kwon YC
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel SARS-CoV-2 variants: the pandemics within the pandemic.
    Boehm E; Kronig I; Neher RA; Eckerle I; Vetter P; Kaiser L;
    Clin Microbiol Infect; 2021 Aug; 27(8):1109-1117. PubMed ID: 34015535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a.
    Joonlasak K; Batty EM; Kochakarn T; Panthan B; Kümpornsin K; Jiaranai P; Wangwiwatsin A; Huang A; Kotanan N; Jaru-Ampornpan P; Manasatienkij W; Watthanachockchai T; Rakmanee K; Jones AR; Fernandez S; Sensorn I; Sungkanuparph S; Pasomsub E; Klungthong C; Chookajorn T; Chantratita W
    Virus Res; 2021 Jan; 292():198233. PubMed ID: 33227343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology.
    Ogando NS; Dalebout TJ; Zevenhoven-Dobbe JC; Limpens RWAL; van der Meer Y; Caly L; Druce J; de Vries JJC; Kikkert M; Bárcena M; Sidorov I; Snijder EJ
    J Gen Virol; 2020 Sep; 101(9):925-940. PubMed ID: 32568027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of SARS-CoV-2 ORF7a Deletions from COVID-19-Positive Individuals and Its Impact on Virus Spread in Cell Culture.
    Simas MCDC; Costa SM; Gomes PDSFC; Cruz NVGD; Corrêa IA; de Souza MRM; Dornelas-Ribeiro M; Nogueira TLS; Santos CGMD; Hoffmann L; Tanuri A; Moura-Neto RS; Damaso CR; Costa LJD; Silva R
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium.
    Touret F; Luciani L; Baronti C; Cochin M; Driouich JS; Gilles M; Thirion L; Nougairède A; de Lamballerie X
    mBio; 2021 Aug; 12(4):e0085021. PubMed ID: 34225487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta.
    Fröba M; Große M; Setz C; Rauch P; Auth J; Spanaus L; Münch J; Ruetalo N; Schindler M; Morokutti-Kurz M; Graf P; Prieschl-Grassauer E; Grassauer A; Schubert U
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excretion of SARS-CoV-2 through faecal specimens.
    Zhang Y; Chen C; Song Y; Zhu S; Wang D; Zhang H; Han G; Weng Y; Xu J; Xu J; Yu P; Jiang W; Yang X; Lang Z; Yan D; Wang Y; Song J; Gao GF; Wu G; Xu W
    Emerg Microbes Infect; 2020 Dec; 9(1):2501-2508. PubMed ID: 33161824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.